Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PROMISE-EC Study: prognostic role of molecular classification and sentinel lymph node status in early-stage endometrial cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Current practices and perceptions of ChatGPT in gynecologic oncology: results from a cross-sectional questionnaire (TRSGO-AI-001).

BMC medical education·2026
Same author

Recurrence of Adult Granulosa Cell Tumors: The Factors Affecting Secondary Recurrence and Survival After Recurrence.

Journal of Cancer·2026
Same author

Survival outcomes in sentinel node-positive vs. -negative endometrial cancer following adjustment for uterine risk factors: a propensity score-matched analysis (TRSGO-SLN-011).

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

ANCA positive pauci-immune glomerulonephritis as presenting feature of mantle cell lymphoma: A case report and review of literature.

Nefrologia·2026
Same author

Hepatic steatosis is associated with HBsAg seroclearance in patients with chronic hepatitis B virus infection but it is also associated with disease progression.

Hepatology forum·2026

Related Experiment Video

Updated: May 25, 2026

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

Expression pattern of PAX2 in hyperplastic and malignant endometrium.

Korhan Kahraman1, Saba Kiremitci, Salih Taskin

  • 1Department of Obstetrics and Gynecology, Ankara University School of Medicine, Ankara, Turkey. korhankahraman@hotmail.com

Archives of Gynecology and Obstetrics
|January 26, 2012
PubMed
Summary

PAX2 (paired box gene 2) expression increases with endometrial hyperplasia and adenocarcinoma progression. This suggests PAX2 may play a role in endometrial cancer development, though it doesn't correlate with tumor stage or grade.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
07:20

Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity

Published on: December 21, 2012

Related Experiment Videos

Last Updated: May 25, 2026

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
07:20

Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity

Published on: December 21, 2012

Area of Science:

  • Gynecologic Oncology
  • Molecular Pathology
  • Cancer Biology

Background:

  • PAX2 (paired box gene 2) is a gene crucial for urogenital system development.
  • Its expression patterns in endometrial pathologies are not fully understood.

Purpose of the Study:

  • To evaluate PAX2 expression in hyperplastic and malignant endometrial tissues.
  • To compare PAX2 expression with non-pathological endometrial changes.
  • To investigate the correlation between PAX2 expression and endometrial tumor behavior.

Main Methods:

  • Immunohistochemical analysis of PAX2 in 121 archival endometrial tissue samples.
  • Study groups included complex hyperplasia, atypical hyperplasia, and endometrioid adenocarcinoma.
  • Control groups comprised proliferative and atrophic endometrium.

Main Results:

  • PAX2 nuclear staining was present in all endometrial tissue types.
  • PAX2 expression significantly increased with endometrial pathology progression (P < 0.001).
  • No correlation was found between PAX2 levels and tumor stage, grade, invasion, or lymph node status in cancer cases.

Conclusions:

  • PAX2 is expressed across a spectrum of endometrial conditions, from normal to malignant.
  • Increasing PAX2 expression correlates with neoplastic progression in the endometrium.
  • PAX2 may be implicated in the pathogenesis of endometrial cancer.